Equitable Trust Co. Has $1.42 Million Stake in Danaher Corporation $DHR

Equitable Trust Co. reduced its stake in shares of Danaher Corporation (NYSE:DHRFree Report) by 41.7% in the 3rd quarter, Holdings Channel reports. The firm owned 7,140 shares of the conglomerate’s stock after selling 5,110 shares during the quarter. Equitable Trust Co.’s holdings in Danaher were worth $1,416,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in DHR. Sivia Capital Partners LLC boosted its holdings in Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after acquiring an additional 119 shares during the last quarter. Kornitzer Capital Management Inc. KS lifted its position in shares of Danaher by 1.0% in the 2nd quarter. Kornitzer Capital Management Inc. KS now owns 9,746 shares of the conglomerate’s stock worth $1,925,000 after purchasing an additional 95 shares during the period. Linden Thomas Advisory Services LLC bought a new stake in shares of Danaher in the 2nd quarter valued at $252,000. Brighton Jones LLC increased its position in shares of Danaher by 47.3% during the second quarter. Brighton Jones LLC now owns 10,390 shares of the conglomerate’s stock worth $2,052,000 after buying an additional 3,335 shares during the period. Finally, Envestnet Asset Management Inc. increased its position in shares of Danaher by 7.5% during the second quarter. Envestnet Asset Management Inc. now owns 1,355,964 shares of the conglomerate’s stock worth $267,850,000 after buying an additional 94,768 shares during the period. Institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on DHR shares. Evercore reaffirmed an “outperform” rating and set a $254.00 price target on shares of Danaher in a research report on Wednesday, January 28th. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research report on Saturday, November 22nd. Robert W. Baird set a $251.00 target price on Danaher in a report on Thursday, January 29th. HSBC increased their price target on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a report on Monday, December 1st. Finally, TD Cowen reiterated a “buy” rating on shares of Danaher in a research note on Wednesday, January 7th. Twenty equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $253.86.

View Our Latest Stock Analysis on Danaher

Insider Activity at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the sale, the executive vice president owned 5,099 shares in the company, valued at $1,060,642.99. This represents a 20.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 11.20% of the stock is currently owned by insiders.

Danaher Trading Up 0.7%

NYSE DHR opened at $210.90 on Tuesday. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $242.80. The business has a 50 day moving average price of $226.49 and a 200-day moving average price of $216.12. The company has a market cap of $148.97 billion, a price-to-earnings ratio of 41.84, a P/E/G ratio of 2.83 and a beta of 0.91.

Danaher (NYSE:DHRGet Free Report) last issued its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company had revenue of $6.84 billion for the quarter, compared to analysts’ expectations of $6.79 billion. During the same period last year, the business earned $2.14 EPS. Danaher’s quarterly revenue was up 4.6% compared to the same quarter last year. As a group, equities analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Friday, December 26th. Danaher’s dividend payout ratio (DPR) is currently 25.40%.

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.